Stock market

Emergent gets $23 million additional order for vaccine production

Stock Markets (Apr 04, 2021 11:25PM ET)Emergent gets $23 million additional order for vaccine production

© Reuters. FILE PHOTO: Vials labelled

(Reuters) – Emergent BioSolutions Inc said late on Sunday that a key U.S. agency has increased an order, related to the manufacturing of Johnson & Johnson (NYSE:JNJ)’s COVID-19 vaccine, by $23 million.

The amount will be used to purchase biologics equipment specific to J&J’s vaccine and support the potential manufacturing expansion at the company’s Baltimore Bayview facility, the company said in a statement.

Emergent also said that it will agree to a mutual ramp down of manufacturing of AstraZeneca (NASDAQ:AZN) Plc’s COVID-19 vaccine bulk drug substance.Emergent gets $23 million additional order for vaccine productionAdd a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s